Start Forschung Abteilungen / AGs / Institute Psychiatrie und Psychotherapie Arbeitsgruppen AG ADHS im Erwachsenenalter Publikationen

Publikationen: ADHS im Erwachsenenalter

Brüggemann D, Sobanski E, Alm B, Schubert T, Schmalzried H, Philipsen A, Phillipsen A, Breen G, Becker T, Georgi A, Skowronek MH, Schulze TG, Treutlein J, Rietschel M. No association between a common haplotype of the 6 and 10-repeat alleles in intron 8 and the 3'UTR of the DAT1 gene and adult attention deficit hyperactivity disorder. Psychiatr Genet. 2007 17(2):121.
Buitelaar JK, Sobanski E, Stieglitz RD, Dejonckheere J, Waechter S, Schäuble B. Predictors of placebo response in adults with attention-deficit/hyperactivity disorder: data from 2 randomized trials of osmotic-release oral system methylphenidate. J Clin Psychiatry. 2012 73(8):1097-102. Epub 2012 Jun 12.
Christiansen H, Hirsch O, Philipsen A, Oades RD, Matthies S, Hebebrand J, Ueckermann J, Abdel-Hamid M, Kraemer M, Wiltfang J, Graf E, Colla M, Sobanski E, Alm B, Rösler M, Jacob C, Jans T, Huss M, Schimmelmann BG, Kis B. German Validation of the Conners Adult ADHD Rating Scale-Self-Report: Confirmation of Factor Structure in a Large Sample of Participants With ADHD. J Atten Disord. 2013 18(8):690-8. Epub 2012 Mar 21.
Christiansen H, Kis B, Hirsch O, Matthies S, Hebebrand J, Uekermann J, Abdel-Hamid M, Kraemer M, Wiltfang J, Graf E, Colla M, Sobanski E, Alm B, Rösler M, Jacob C, Jans T, Huss M, Schimmelmann BG, Philipsen A. German validation of the Conners Adult ADHD Rating Scales (CAARS) II: Reliability, validity, diagnostic sensitivity and specificity. Eur Psychiatry. 2012 27(5):321-8. Epub 2011 Mar 9..
Colla M, Ende G, Alm B, Deuschle M, Heuser I, Kronenberg G. Cognitive MR spectroscopy of anterior cingulate cortex in ADHD: elevated choline signal correlates with slowed hit reaction times. J Psychiatr Res. 2008 42(7):587-95.
Englisch S, Alm B, Meyer-Lindenberg A, Zink M. Pregabalin-associated increase of clozapine serum levels. J Clin Psychopharmacol. 2012 32(1):127.
Grimm O, Alm B, Für Seelische Z. A case of ciprofloxacin-induced acute polymorphic psychosis with a distinct deficit in executive functions. Psychosomatics. 2007 48(3):269.
Jans T, Graf E, Jacob C, Zwanzger U, Groß-Lesch S, Matthies S, Perlov E, Hennighausen K, Jung M, Rösler M, Schulte-Altedorneburg M, von Gontard A, Hänig S, Sobanski E, Alm B, Poustka L, Bliznak L, Colla M, Gentschow L, Burghardt R, Salbach-Andrae H, Becker K, Holtmann M, Freitag C, Warnke A, Philipsen A. A randomized controlled multicentre trial on the treatment for ADHD in mothers and children: enrolment and basic characteristics of the study sample. Atten Defic Hyperact Disord. 2013 5(1):29-40. Epub 2012 Oct. 16.
Kotsopoulos N, Connolly MP, Sobanski E, Postma MJ. The fiscal consequences of ADHD in Germany: a quantitative analysis based on differences in educational attainment and lifetime earnings. J Ment Health Policy Econ. 2013 16(1):27-33.
Krause-Utz A, Sobanski E, Alm B, Valerius G, Kleindienst N, Bohus M, Schmahl C. Impulsivity in Relation to Stress in Patients With Borderline Personality Disorder With and Without Co-occurring Attention-Deficit/Hyperactivity Disorder: An Exploratory Study. J Nerv Ment Dis. 2013 201(2):116-23.
Kronenberg G, Ende G, Alm B, Deuschle M, Heuser I, Colla M. Increased NAA and reduced choline levels in the anterior cingulum following chronic methylphenidate. A spectroscopic test-retest study in adult ADHD. Eur Arch Psychiatry Clin Neurosci. 2008 258(7):446-50.
Nolte D, Sobanski E, Wissen A, Regula JU, Lichy C, Müller U. Spinocerebellar ataxia type 17 associated with an expansion of 42 glutamine residues in TATA-box binding protein gene. J Neurol Neurosurg Psychiatry. 2010 81(12):1396-9.
Paslakis G, Kiefer F, Diehl A, Alm B, Sobanski E. [Methylphenidate. Therapy option for adults with ADHD and comorbid substance use disorder?]. Nervenarzt. 2010 81(3):277-88.
Paslakis G, Schredl M, Alm B, Sobanski E. [Adult Attention Deficit/Hyperactivity Disorder, Associated Symptoms and Comorbid Psychiatric Disorders: Diagnosis and Pharmacological Treatment.]. Fortschr Neurol Psychiatr. 2013 81(8):444-51. Epub 2013 Jul 17.
Philipsen A, Graf E, Jans T, Matthies S, Borel P, Colla M, Gentschow L, Langner D, Jacob C, Groß-Lesch S, Sobanski E, Alm B, Schumacher-Stien M, Roesler M, Retz W, Retz-Junginger P, Kis B, Abdel-Hamid M, Heinrich V, Huss M, Kornmann C, Bürger A, van Elst LT, Berger M. A randomized controlled multicenter trial on the multimodal treatment of adult attention-deficit hyperactivity disorder: enrollment and characteristics of the study sample. Atten Defic Hyperact Disord. 2014 3(1):35-47. Epub 2013 Oct 17.
Philipsen A, Graf E, Tebartz van Elst L, Jans T, Warnke A, Hesslinger B, Ebert D, Gerlach M, Matthies S, Colla M, Jacob C, Sobanski E, Alm B, Rösler M, Ihorst G, Gross-Lesch S, Gentschow L, Kis B, Huss M, Lieb K, Schlander M, Berger M. Evaluation of the efficacy and effectiveness of a structured disorder tailored psychotherapy in ADHD in adults: study protocol of a randomized controlled multicentre trial. Atten Defic Hyperact Disord. 2010 2(4):203-12.
Philipsen A, Richter H, Peters J, Alm B, Sobanski E, Colla M, Münzebrock M, Scheel C, Jacob C, Perlov E, Tebartz van Elst L, Hesslinger B. Structured group psychotherapy in adults with attention deficit hyperactivity disorder: results of an open multicentre study. J Nerv Ment Dis. 2007 195(12):1013-9.
Ramos-Quiroga JA, Montoya A, Kutzelnigg A, Deberdt W, Sobanski E. Attention Deficit Hyperactivity Disorder in the European Adult Population: Prevalence, Disease Awareness, and Treatment Guidelines. Curr Med Res Opin. 2013 29(9):1093-104. Epub 2013 Jun 7.
Retz W, Rösler M, Ose C, Scherag A, Alm B, Philipsen A, Fischer R, Ammer R. Multiscale assessment of treatment efficacy in adults with ADHD: A randomized placebo-controlled, multi-centre study with extended-release methylphenidate. World J Biol Psychiatry. 2012 13(1):48-59. Epub 2010 Dec 14.
Rösler M, Retz W, Fischer R, Ose C, Alm B, Deckert J, Philipsen A, Herpertz S, Ammer R. Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD. World J Biol Psychiatry. 2010 11(5):709-18. Epub 2010 Mar 30.
Schredl M, Alm B, Sobanski E. Sleep quality in adult patients with attention deficit hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci. 2007 257(3):164-8.
Sobanski E. Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci. 2006 256 Suppl 1:i26-31.
Sobanski E, Alm B, Krumm B. Methylphenidatebehandlung bei Erwachsenen mit Aufmerksamkeitsdefizit- / Hyperaktivitätsstörung. Nervenarzt. 2007 78(3):328-37.
Sobanski E, Banaschewski T, Asherson P, Buitelaar J, Chen W, Franke B, Holtmann M, Krumm B, Sergeant J, Sonuga-Barke E, Stringaris A, Taylor E, Anney R, Ebstein RP, Gill M, Miranda A, Mulas F, Oades RD, Roeyers H, Rothenberger A, Steinhausen HC, Faraone SV. Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence. J Child Psychol Psychiatry. 2010 51(8):915-23. Epub 2010 Feb 1.
Sobanski E, Brüggemann D, Alm B, Kern S, Deschner M, Schubert T, Philipsen A, Rietschel M. Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci. 2007 257(7):371-7.
Sobanski E, Brüggemann D, Alm B, Kern S, Philipsen A, Schmalzried H, Hesslinger B, Waschkowski H, Rietschel M. Subtype differences in adults with attention-deficit/hyperactivity disorder (ADHD) with regard to ADHD-symptoms, psychiatric comorbidity and psychosocial adjustment. Eur Psychiatry. 2008 23(2):142-9.
Sobanski E, Döpfner M, Ose C, Fischer R. A non-interventional study of extended-release methylphenidate in the routine treatment of adolescents with ADHD: effectiveness, safety and adherence to treatment. Atten Defic Hyperact Disord. 2013 5(4):389-95. Epub 2013 Jun 23.
Sobanski E, Retz W, Fischer R, Ose C, Alm B, Hennig O, Rösler M. Treatment adherence and persistence in adult ADHD: results from a twenty-four week controlled clinical trial with extended release methylphenidate. Eur Psychiatry. 2014 29(5):324-30.
Sobanski E, Sabljic D, Alm B, Baehr C, Dittmann RW, Skopp G, Strohbeck-Kuehner P. A Randomized, Waiting List-Controlled 12-Week Trial of Atomoxetine in Adults with ADHD. Pharmacopsychiatry. 2012 45:100-107. Epub 2011 Dec 15.
Sobanski E, Sabljic D, Alm B, Dittmann RW, Wehmeier PM, Skopp G, Strohbeck-Kühner P. Driving performance in adults with ADHD: Results from a randomized, waiting list controlled trial with atomoxetine. Eur Psychiatry. 2013 28(6):379-85. Epub 2012 Oct 9.
Sobanski E, Sabljic D, Alm B, Skopp G, Kettler N, Mattern R, Strohbeck-Kühner P. Driving-related risks and impact of methylphenidate treatment on driving in adults with attention-deficit/hyperactivity disorder (ADHD). J Neural Transm. 2008 115(2):347-56.
Weniger T, Alm B, Sobanski E. [For and against: attention deficit syndrome (ADS)--a diagnosis that neither helps patients nor therapists]. Psychiatr Prax. 2007 34(1):4-6.
Zink M, Schirmbeck F, Rausch F, Eifler S, Elkin H, Solojenkina X, Englisch S, Wagner M, Maier W, Lautenschlager M, Heinz A, Gudlowski Y, Janssen B, Gaebel W, Michel TM, Schneider F, Lambert M, Naber D, Juckel G, Krueger-Oezguerdal S, Wobrock T, Hasan A, Riedel M, Müller H, Klosterkötter J, Bechdolf A. Obsessive-compulsive symptoms in at-risk mental states for psychosis: associations with clinical impairment and cognitive function. Acta Psychiatr Scand. 2014 130(3):214-26. Epub 2014 Feb 26.


Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de